Pressure BioSciences, Inc. (PBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0001 (16.67%)
At close: Dec 5, 2025
Pressure BioSciences Revenue
Pressure BioSciences had revenue of $421.79K in the quarter ending June 30, 2024, a decrease of -17.59%. This brings the company's revenue in the last twelve months to $1.50M, down -25.31% year-over-year. In the year 2023, Pressure BioSciences had annual revenue of $1.98M with 14.36% growth.
Revenue (ttm)
1.50M
Revenue Growth
-25.31%
P/S Ratio
0.02
Revenue / Employee
93.53K
Employees
16
Market Cap
30.08K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.98M | 248.42K | 14.36% |
| Dec 31, 2022 | 1.73M | -273.02K | -13.63% |
| Dec 31, 2021 | 2.00M | 781.77K | 64.05% |
| Dec 31, 2020 | 1.22M | -589.40K | -32.56% |
| Dec 31, 2019 | 1.81M | -647.88K | -26.36% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| Northwest Biotherapeutics | 937.00K |
Pressure BioSciences News
- 1 year ago - Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray - GlobeNewsWire
- 1 year ago - Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET - GlobeNewsWire
- 1 year ago - Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET - GlobeNewsWire
- 1 year ago - Pressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection” - GlobeNewsWire
- 1 year ago - Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc. - GlobeNewsWire
- 1 year ago - Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing - GlobeNewsWire
- 1 year ago - Pressure BioSciences, Inc. (PBIO) Acquisition of Uncle Bud's Conference Call (Transcript) - Seeking Alpha
- 1 year ago - Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness - GlobeNewsWire